A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Ethyl loflazepate
Bufuralol
Acemetacin may decrease the antihypertensive activities of Bufuralol.
Ethyl loflazepate
Nebivolol
Acemetacin may decrease the antihypertensive activities of Nebivolol.
Ethyl loflazepate
Celiprolol
Acemetacin may decrease the antihypertensive activities of Celiprolol.
Ethyl loflazepate
Dexpropranolol
Acemetacin may decrease the antihypertensive activities of Dexpropranolol.
Ethyl loflazepate
Cilazaprilat
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Acemetacin is combined with Cilazaprilat.
Ethyl loflazepate
Quinoline Yellow WS
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Acemetacin is combined with Quinoline Yellow WS.
Ethyl loflazepate
Quinaprilat
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Acemetacin is combined with Quinaprilat.
Ethyl loflazepate
Perindoprilat
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Acemetacin is combined with Perindoprilat.
Ethyl loflazepate
Moexiprilat
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Acemetacin is combined with Moexiprilat.
Ethyl loflazepate
Trandolaprilat
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Acemetacin is combined with Trandolaprilat.
Ethyl loflazepate
Ramiprilat
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Acemetacin is combined with Ramiprilat.
Ethyl loflazepate
Fosinoprilat
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Acemetacin is combined with Fosinoprilat.
Ethyl loflazepate
Benazeprilat
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Acemetacin is combined with Benazeprilat.
Ethyl loflazepate
Delapril
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Acemetacin is combined with Delapril.
Ethyl loflazepate
Zofenopril
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Acemetacin is combined with Zofenopril.
Ethyl loflazepate
Imidapril
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Acemetacin is combined with Imidapril.
Ethyl loflazepate
Enalaprilat
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Acemetacin is combined with Enalaprilat.
Ethyl loflazepate
Candesartan
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Candesartan is combined with Acemetacin.
Ethyl loflazepate
Azilsartan medoxomil
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Azilsartan medoxomil is combined with Acemetacin.
Ethyl loflazepate
Saralasin
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Saralasin is combined with Acemetacin.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3